John Desjarlais, PhDChief Scientific Officer at Xencor, Inc.Speaker
Profile
John Desjarlais is the Chief Scientific Officer of Xencor, where he and his team have built a variety of antibody engineering and enhancement platforms, leading to multiple clinical-stage and approved antibody programs. Prior to Xencor, John was an Assistant Professor of Chemistry at Penn State University. His education includes a Postdoctoral Fellowship at UC Berkeley, a PhD in Biophysics from Johns Hopkins University, and a BS in Physics from UMass Amherst.
Agenda Sessions
Bispecific Antibodies for Oncology and Autoimmune Diseases
, 11:30amView SessionChairman’s Remarks - Antibody-Based Approaches to Treat Autoimmunity
, 2:25pmView Session